The use of protein phosphatase 2A activators in combination therapies for pancreas cancer
Oncotarget
.
2019 Mar 12;10(21):2008-2009.
doi: 10.18632/oncotarget.26772.
Authors
Brittany L Allen-Petersen
1
,
Rosalie C Sears
1
Affiliation
1
Rosalie C. Sears: Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR, USA.
PMID:
31007842
PMCID:
PMC6459339
DOI:
10.18632/oncotarget.26772
No abstract available
Keywords:
MYC; PP2A; pancreatic cancer.
Publication types
Editorial